Limits...
Efficacy and safety of endovascular treatment versus intravenous thrombolysis for acute ischemic stroke: a meta-analysis of randomized controlled trials.

Lin C, Li N, Wang K, Zhao X, Li BQ, Sun L, Lin YX, Fan JM, Zhang M, Sun HC - PLoS ONE (2013)

Bottom Line: ET and IVT were associated with similar good (43.06% vs 41.78%; OR=1.14; 95% CI, 0.77 to 1.69; P=0.52;) and excellent (30.43% vs 30.42%; OR=1.05; 95% CI, 0.80 to 1.38; P=0.72;) outcome.For additional end points, ET was not associated with increased occurrence of symptomatic hemorrhage (6.25% vs. 6.22%; OR=1.03; 95% CI, 0.62 to 1.69; P=0.91;), or all-cause mortality (18.45% vs. 17.35%; OR=1.00; 95% CI, 0.73 to 1.39; P=0.99;).Formal meta-analysis indicates that there are similar safety outcomes and functional independence with endovascular therapy and intravenous thrombolysis for acute ischemic stroke.

View Article: PubMed Central - PubMed

Affiliation: Department of Neurosurgery, Jinling Hospital, Nanjing University, Nanjing, China.

ABSTRACT

Background and purpose: Although endovascular therapy (ET) is increasingly used in patients with moderate to severe acute ischemic stroke, its efficacy and safety remains controversial. We performed a meta-analysis aiming to compare the benefits and safety of endovascular treatment and intravenous thrombolysis in the treatment of acute ischemic stroke.

Methods: We systematically searched PubMed, Embase, Science direct and Springer unitil July, 2013. The primary outcomes included good outcome (mRS ≤ 2) and excellent outcome (mRS ≤ 1) at 90 days or at trial end point. Secondary outcomes were occurrence of symptomatic hemorrhage and all-cause mortality.

Results: Using a prespecified search strategy, 5 RCTs with 1106 patients comparing ET and intravenous thrombolysis (IVT) were included in the meta-analysis. ET and IVT were associated with similar good (43.06% vs 41.78%; OR=1.14; 95% CI, 0.77 to 1.69; P=0.52;) and excellent (30.43% vs 30.42%; OR=1.05; 95% CI, 0.80 to 1.38; P=0.72;) outcome. For additional end points, ET was not associated with increased occurrence of symptomatic hemorrhage (6.25% vs. 6.22%; OR=1.03; 95% CI, 0.62 to 1.69; P=0.91;), or all-cause mortality (18.45% vs. 17.35%; OR=1.00; 95% CI, 0.73 to 1.39; P=0.99;).

Conclusions: Formal meta-analysis indicates that there are similar safety outcomes and functional independence with endovascular therapy and intravenous thrombolysis for acute ischemic stroke.

Show MeSH

Related in: MedlinePlus

Other adverse effects of patients treated with Endovascular Therapy and Intravenous Thrombolysis after acute ischemic stroke.(A) Forest plot of RR and 95% CI for the occurrence of Neurologic deterioration at Day 7 in patients assigned to Endovascular Therapy and Intravenous Thrombolysis. (B) Forest plot of RR and 95% CI for the occurrence of recurrent ischemic stroke in patients assigned to Endovascular Therapy and Intravenous Thrombolysis. (C) Forest plot of RR and 95% CI for the occurrence of cerebral edema in patients assigned to Endovascular Therapy and Intravenous Thrombolysis.
© Copyright Policy
Related In: Results  -  Collection


getmorefigures.php?uid=PMC3814965&req=5

pone-0077849-g004: Other adverse effects of patients treated with Endovascular Therapy and Intravenous Thrombolysis after acute ischemic stroke.(A) Forest plot of RR and 95% CI for the occurrence of Neurologic deterioration at Day 7 in patients assigned to Endovascular Therapy and Intravenous Thrombolysis. (B) Forest plot of RR and 95% CI for the occurrence of recurrent ischemic stroke in patients assigned to Endovascular Therapy and Intravenous Thrombolysis. (C) Forest plot of RR and 95% CI for the occurrence of cerebral edema in patients assigned to Endovascular Therapy and Intravenous Thrombolysis.

Mentions: For additional end points, there was no significant difference in neurologic deterioration at Day 7 (12.14% vs 11.90%; OR = 1.09; 95% CI, 0.58 to 2.04; P=0.79),recurrent ischemic stroke (4.23% vs 4.47%; OR = 0,83; 95% CI, 0.45 to 1.55; P=0.56), and cerebral edema (19.63% vs 18.75%; OR = 1.06; 95% CI, 0.66 to 1.70; P=0.81) between tow groups (Figure 4).


Efficacy and safety of endovascular treatment versus intravenous thrombolysis for acute ischemic stroke: a meta-analysis of randomized controlled trials.

Lin C, Li N, Wang K, Zhao X, Li BQ, Sun L, Lin YX, Fan JM, Zhang M, Sun HC - PLoS ONE (2013)

Other adverse effects of patients treated with Endovascular Therapy and Intravenous Thrombolysis after acute ischemic stroke.(A) Forest plot of RR and 95% CI for the occurrence of Neurologic deterioration at Day 7 in patients assigned to Endovascular Therapy and Intravenous Thrombolysis. (B) Forest plot of RR and 95% CI for the occurrence of recurrent ischemic stroke in patients assigned to Endovascular Therapy and Intravenous Thrombolysis. (C) Forest plot of RR and 95% CI for the occurrence of cerebral edema in patients assigned to Endovascular Therapy and Intravenous Thrombolysis.
© Copyright Policy
Related In: Results  -  Collection

Show All Figures
getmorefigures.php?uid=PMC3814965&req=5

pone-0077849-g004: Other adverse effects of patients treated with Endovascular Therapy and Intravenous Thrombolysis after acute ischemic stroke.(A) Forest plot of RR and 95% CI for the occurrence of Neurologic deterioration at Day 7 in patients assigned to Endovascular Therapy and Intravenous Thrombolysis. (B) Forest plot of RR and 95% CI for the occurrence of recurrent ischemic stroke in patients assigned to Endovascular Therapy and Intravenous Thrombolysis. (C) Forest plot of RR and 95% CI for the occurrence of cerebral edema in patients assigned to Endovascular Therapy and Intravenous Thrombolysis.
Mentions: For additional end points, there was no significant difference in neurologic deterioration at Day 7 (12.14% vs 11.90%; OR = 1.09; 95% CI, 0.58 to 2.04; P=0.79),recurrent ischemic stroke (4.23% vs 4.47%; OR = 0,83; 95% CI, 0.45 to 1.55; P=0.56), and cerebral edema (19.63% vs 18.75%; OR = 1.06; 95% CI, 0.66 to 1.70; P=0.81) between tow groups (Figure 4).

Bottom Line: ET and IVT were associated with similar good (43.06% vs 41.78%; OR=1.14; 95% CI, 0.77 to 1.69; P=0.52;) and excellent (30.43% vs 30.42%; OR=1.05; 95% CI, 0.80 to 1.38; P=0.72;) outcome.For additional end points, ET was not associated with increased occurrence of symptomatic hemorrhage (6.25% vs. 6.22%; OR=1.03; 95% CI, 0.62 to 1.69; P=0.91;), or all-cause mortality (18.45% vs. 17.35%; OR=1.00; 95% CI, 0.73 to 1.39; P=0.99;).Formal meta-analysis indicates that there are similar safety outcomes and functional independence with endovascular therapy and intravenous thrombolysis for acute ischemic stroke.

View Article: PubMed Central - PubMed

Affiliation: Department of Neurosurgery, Jinling Hospital, Nanjing University, Nanjing, China.

ABSTRACT

Background and purpose: Although endovascular therapy (ET) is increasingly used in patients with moderate to severe acute ischemic stroke, its efficacy and safety remains controversial. We performed a meta-analysis aiming to compare the benefits and safety of endovascular treatment and intravenous thrombolysis in the treatment of acute ischemic stroke.

Methods: We systematically searched PubMed, Embase, Science direct and Springer unitil July, 2013. The primary outcomes included good outcome (mRS ≤ 2) and excellent outcome (mRS ≤ 1) at 90 days or at trial end point. Secondary outcomes were occurrence of symptomatic hemorrhage and all-cause mortality.

Results: Using a prespecified search strategy, 5 RCTs with 1106 patients comparing ET and intravenous thrombolysis (IVT) were included in the meta-analysis. ET and IVT were associated with similar good (43.06% vs 41.78%; OR=1.14; 95% CI, 0.77 to 1.69; P=0.52;) and excellent (30.43% vs 30.42%; OR=1.05; 95% CI, 0.80 to 1.38; P=0.72;) outcome. For additional end points, ET was not associated with increased occurrence of symptomatic hemorrhage (6.25% vs. 6.22%; OR=1.03; 95% CI, 0.62 to 1.69; P=0.91;), or all-cause mortality (18.45% vs. 17.35%; OR=1.00; 95% CI, 0.73 to 1.39; P=0.99;).

Conclusions: Formal meta-analysis indicates that there are similar safety outcomes and functional independence with endovascular therapy and intravenous thrombolysis for acute ischemic stroke.

Show MeSH
Related in: MedlinePlus